Please login to the form below
HR
This page shows the latest HR news and features for those working in and with pharma, biotech and healthcare.
Kisqali combination follows Verzenio onto Cancer Drugs Fund
Ibrance and Kisqali gained NICE approval for first line treatment of hormone receptor (HR) positive, HER2 negative locally advanced or secondary breast cancer in November 2017, while Lilly’s drug only
Latest news
-
Venclexta plus Gazyva approval adds to non-chemo options in CLL
plus chlorambucil, a current standard-of-care (HR=0.33; 95% CI 0.22-0.51; p< 0.0001).
-
NICE says no to Novartis’ Kisqali combo in breast cancer
Kisqali, Verzenio as well as Pfizer’s market-leading CDK 4/6 inhibitor Ibrance (palbociclib) are already recommended for first-line use in HR-positive, HER2-negative advanced breast cancer in
-
AVEO warns EU approval of Fotivda could be at risk
revealed a hazard ratio (HR) of 1.12 for Fotivda, in other words showing a12% higher rate of death than the control population.
-
NICE nod for Lilly’s breast cancer drug Verzenio via CDF
The cost-effectiveness watchdog has opted to make Verzenio (abemaciclib) plus fulvestrant available to around 4, 800 women with hormone receptor (HR) positive, HER2-negative breast cancer which has spread to ... s Ibrance (palbociclib) – which have
-
GCI Health expands into Asia, Lucid adds to Futures Academy and more
Angela Young, HR Director commented, “The Futures Academy provides a fantastic platform for graduates entering into the industry to learn from the best, get inspired, explore their talents and realise their
More from news
Approximately 1 fully matching, plus 49 partially matching documents found.
Latest Intelligence
-
Evolve, evolve, evolve; a call to action to all leaders in the healthcare industry
At a recent HR Conference, TogetHR in Basel, a seven-point manifesto for change was produced that identified a greater set of ‘core skills’ as the key to competitive advantage – for
-
Whenever, wherever – the new face of flexible working
Candidates ask about our dynamic working policy in every single interview,” says Sonia Hall, Director of HR at Pegasus, “and it’s often been a clincher when they have been deciding
-
Leave or remain? Winning the employee referendum
We all know you. can’t run a business on 50% turnover, but low employee turnover can also be damaging,” says Liam Mulvihill, European HR Director, Commercial Solutions, Syneos Health.
-
Diversity and inclusion in the pharma industry
This has been acknowledged as negatively affecting BAME employee advancement. Unless we build inclusive cultures and related HR practices that can consistently support BAME talent in the same way as Lesbian,
-
Revenue down the back of the beanbag
How to engage with employees to create a sophisticated strategy. Business leaders and HR professionals have become a little millennial-obsessed. It is a modern day leadership pre-requisite to consider ... Liam Mulvihill is HR Director of Syneos Health
More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Sobi poaches Pfizer’s Fredrick Wetterlundh
Joining from pharma giant Pfizer, Wetterlundh most recently held the position of global human resources lead, gaining extensive experience in leading business-driven HR organisations, processes and projects in Asia, Europe,
-
Ipsen bolsters leadership team
There he led a global HR team of over 600 people, cultivating talent development and strategic planning. ... Prior to his time at Staples, Mulot has held HR leadership positions with Levi Strauss &Co and technology start-up Broadnet Europe.
-
Adare appoints Sharon Frost as HR director
She joins the marketing communications firm from Cognita
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
She joins the biotech from Sobi
-
Axon appoints Antonia Katsambis
She joins the firm as its HR director. Axon Communications has appointed a new human resources (HR) director in the form of Antonia Katsambis. ... Her new role will see her lead HR-related initiatives for both Axon and its sister agency Madano.
More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
After a busy first quarter, emotive welcomes five new team members
Finally, we welcome Gemma as Talent Manager. As the agency continues to grow apace, Gemma will support the HR team as an in-house resource to attract and develop the amazing ... She also holds a level 5 CIPD in HR management achieved during her
-
GCI Health continues to go from strength to strength, with significant new hires
Zoe Fleming, Director HR, Zoe.Fleming@gcihealth.com 44 (0) 7714 165788.
-
Lucid Group Let Loose with the Launch of ‘Summer Fridays’
Angela Young, HR Director commented, “Agile working is something we take very seriously at Lucid and we’ve already made a significant investment in our infrastructure to support our approach across
-
Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects
Lucid group is excited to announce the appointment of its new head of Talent, Resourcing and HR projects, Olivia Emirali. ... Olivia joined Lucid in March this year to review recruitment and has already had a tremendous impact on HR and the wider business
-
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Kate McCabe, HR manager who is responsible for the initiative talked about what it takes to become a Platinum award winner.
More from PMHub
Approximately 1 fully matching, plus 45 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
